Article Information
History
- February 29, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Mengshi Yi, MD#,1,
- Rui Zhao, MD#,1,
- Qianyi Wan, MD1,
- Xiaoting Wu, MD1,
- Wen Zhuang, MD1,
- Hanshuo Yang, MD2,
- Chuncheng Wu, MD3,
- Lin Xia, MD1,
- Yi Chen, MD1 and
- Yong Zhou, MD*,1
- 1Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, 610041, China
- 2State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, 610041, China
- 3Department of Digestive Medical, West China Hospital, Sichuan University, Chengdu, 610041, China
- ↵*Corresponding author: Prof. Yong Zhou, Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, 37 Guo Xue Rd, Chengdu 610041, Sichuan Province, China. Email: nutritioner{at}hotmail.com
↵# The authors contribute equally to this work
Posted February 29, 2020.
Tumor-infiltrating immune cells signature predicts recurrence free survival after complete resection of localized primary gastrointestinal stromal tumors
